Gastrointestinal Cancer
News
Inhibiting adenosine pathways may be key to CRC treatment
New research suggests mechanisms behind how adenosine leads to immunosuppression in the tumor microenvironment.
From the Journals
After index colonoscopy, what’s the CRC risk in 40- to 49-year-olds vs. 50- to 59-year-olds?
Advanced neoplasia risk is lower in younger patients when no adenoma is detected on index colonoscopy, new research indicates.
From the Journals
Taking the heat out of coffee’s esophageal cancer risk
“It is, therefore, plausible that a carcinogenic effect of coffee relates to thermal injury broadly, rather than being specific to coffee or its...
From the Journals
Ultraprocessed foods tied to higher risk for CRC, death from heart disease
Two new studies provide more evidence to support policies that limit ultraprocessed foods and promote consumption of fresh or minimally processed...
News from the FDA/CDC
Intera Oncology recalls hepatic artery infusion pumps for possible life-threatening issue
The recall follows reports from clinicians that the pumps, which are implanted to deliver chemotherapy to treat liver tumors, were delivering...
From the Journals
New model could boost BE screening, early diagnosis
The predictive model relies on factors readily available in EHRs and could potentially be automated using e-Trigger tools.
From the Journals
Fine-needle aspiration alternative allows closer look at pancreatic cystic lesions
Through-the-needle microforceps biopsy allow next-generation sequencing to be paired with histology for accurate results.
From the Journals
Erlotinib promising for cancer prevention in familial adenomatous polyposis
After 6 months of weekly erlotinib, duodenal polyp burden was significantly reduced, with a mean percent reduction of 29.6%.
From the Journals
Pervasive ‘forever chemical’ linked to liver cancer
People can limit exposure by avoiding water contaminated with ‘forever chemicals’ or filtering it.
From the Journals
Can folic acid halt or reverse progression of gastric precancerous conditions?
A meta-analysis suggests folic acid supplementation has the potential to halt or even reverse progression of gastric precancerous conditions.
From the Journals
Lung adverse effects in patients taking trastuzumab deruxtecan
Close monitoring and proactive management may reduce the risk of ILD.